SpotLite360 IOT Solutions, Inc. (SPLTF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
SpotLite360 IOT Solutions, Inc. (SPLTF) with AI Score 42/100 (Grade C). SpotLite360 IOT Solutions, Inc. is a software as a service (SaaS) company providing supply chain solutions. Sector: Healthcare.
Last analyzed: Mar 18, 2026SPLTF: the 1 perspectives are evenly split.
SpotLite360 IOT Solutions, Inc. (SPLTF) Healthcare & Pipeline Overview
SpotLite360 IOT Solutions, Inc. offers a SaaS-based supply chain platform, Spotlite360, targeting pharmaceutical, healthcare, logistics, and agricultural sectors. The company's solutions emphasize tracing, tracking, and sustainability, positioning it within the growing market for supply chain visibility and optimization technologies.
What Is the Investment Thesis for SPLTF?
SpotLite360 operates in the growing market for supply chain visibility solutions, particularly within regulated industries like pharmaceuticals. The company's SaaS model provides recurring revenue potential, and its focus on sustainability aligns with current market trends. However, the company's negative profit margin of -124674.9% and gross margin of -601.7% raise concerns about its financial sustainability. Key catalysts include expanding its customer base and further developing its platform's capabilities. Investors should closely monitor the company's ability to improve its financial performance and achieve profitability.
Based on FMP financials and quantitative analysis
SPLTF Key Highlights
- Market Cap of $0.01B indicates a micro-cap company with potential for high growth but also significant risk.
- P/E ratio of -0.16 reflects current losses and makes valuation challenging.
- Profit Margin of -124674.9% signals significant operational inefficiencies and the need for substantial improvement.
- Gross Margin of -601.7% indicates that the company's cost of goods sold far exceeds its revenue, raising concerns about its business model.
- Beta of 0.61 suggests the stock is less volatile than the overall market.
Who Are SPLTF's Competitors?
Who Are SPLTF's Competitors?
SPLTF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| DVHGF Devonian Health Group Inc. | $10.65 | +0.00% | $29.62M | 47 |
| HNGE Hinge Health, Inc. | $54.50 | +1.15% | 5B | 68 |
| VRHI Veri Medtech Holdings Inc. | $1.00 | +0.00% | $20.00M | 67 |
| CRBKF Carebook Technologies Inc. | $0.03 | +0.00% | $6.84M | 64 |
| FOXO FOXO Technologies Inc. | $0.00 | +0.00% | 3K | 63 |
| NH NantHealth, Inc. | $1.35 | +0.00% | 52 | |
| DOCS Doximity, Inc. | $21.40 | +1.57% | $4.00B | 52 |
| DH Definitive Healthcare Corp. | $0.91 | +3.36% | 96M | 52 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SPLTF's Key Strengths?
- SaaS-based platform provides recurring revenue potential.
- Focus on specific industries allows for tailored solutions.
- Emphasis on sustainability aligns with market trends.
- Platform offers end-to-end supply chain visibility.
What Are SPLTF's Weaknesses?
- Negative profit margin raises concerns about financial sustainability.
- Limited market share compared to established competitors.
- Reliance on a single platform for revenue generation.
- OTC listing may limit investor access and liquidity.
What Could Drive SPLTF Stock Higher?
- Expansion into new geographic markets, such as Europe, could drive revenue growth.
- Strategic partnerships with logistics providers could broaden customer reach.
- Increasing demand for supply chain visibility and sustainability is a long-term tailwind.
- Development of advanced analytics capabilities could enhance the platform's value proposition.
What Are the Key Risks for SPLTF?
- Intense competition from established players could limit market share gains.
- Technological advancements could render the platform obsolete.
- Economic downturn could reduce demand for supply chain solutions.
- Negative profit margin raises concerns about financial sustainability.
- OTC listing may limit investor access and liquidity.
What Are the Growth Opportunities for SPLTF?
- Expansion into the pharmaceutical sector: The pharmaceutical industry faces stringent regulatory requirements and increasing pressure to ensure product integrity throughout the supply chain. SpotLite360's platform can address these needs by providing end-to-end tracking and tracing capabilities. The global pharmaceutical supply chain market is estimated to reach $1.6 trillion by 2027, presenting a significant opportunity for SpotLite360 to capture market share by offering specialized solutions.
- Penetration of the agricultural industry: The agricultural sector is increasingly focused on sustainability and traceability to meet consumer demand for ethically sourced and environmentally friendly products. SpotLite360's platform can help agricultural companies track their products from farm to table, providing transparency and building consumer trust. The market for agricultural traceability solutions is projected to reach $5 billion by 2028, offering a substantial growth opportunity for SpotLite360.
- Strategic partnerships with logistics providers: Collaborating with logistics companies can enable SpotLite360 to integrate its platform into existing supply chain infrastructure and reach a wider customer base. Logistics providers are seeking to enhance their services with technology solutions that improve efficiency and visibility. By partnering with these companies, SpotLite360 can gain access to new markets and accelerate its growth. The global logistics market is valued at over $10 trillion, indicating the potential for significant revenue generation through strategic alliances.
- Development of advanced analytics capabilities: Integrating advanced analytics into the Spotlite360 platform can provide customers with valuable insights into their supply chain performance, enabling them to identify areas for improvement and optimize their operations. The market for supply chain analytics is growing rapidly, driven by the increasing availability of data and the demand for data-driven decision-making. By offering advanced analytics, SpotLite360 can differentiate its platform and attract customers seeking to gain a competitive edge.
- Geographic expansion into Europe: The European market presents a significant opportunity for SpotLite360 to expand its reach and diversify its customer base. Europe has stringent regulations regarding product traceability and sustainability, creating a demand for solutions like Spotlite360's platform. By establishing a presence in Europe, SpotLite360 can tap into a large and growing market for supply chain solutions. The European supply chain management market is projected to reach $200 billion by 2025, indicating the potential for substantial revenue growth.
What Opportunities Does SPLTF Have?
- Expansion into new industries and geographic markets.
- Strategic partnerships with logistics providers.
- Development of advanced analytics capabilities.
- Increasing demand for supply chain visibility and sustainability.
What Threats Does SPLTF Face?
- Intense competition from established players.
- Technological advancements could render the platform obsolete.
- Economic downturn could reduce demand for supply chain solutions.
- Regulatory changes could impact the company's operations.
What Are SPLTF's Competitive Advantages?
- Proprietary SaaS platform with specialized features.
- Focus on specific industries creates expertise and differentiation.
- Emphasis on sustainability aligns with growing market demand.
What Does SPLTF Do?
SpotLite360 Technologies, Inc., established in 2014 and headquartered in Vancouver, Canada, operates as a software as a service (SaaS) provider. The company's core offering, Spotlite360, is a platform designed to enhance supply chain execution, tracing, tracking, and sustainability. Spotlite360 targets enterprise clients across several sectors, including pharmaceuticals, healthcare, logistics, and agriculture. The platform aims to provide end-to-end visibility and control over supply chains, addressing critical needs for product integrity, regulatory compliance, and operational efficiency. Spotlite360's focus on sustainability also aligns with increasing corporate and consumer demand for environmentally responsible practices. The company currently serves clients in Canada and the United States.
What Products and Services Does SPLTF Offer?
- Provides a SaaS-based supply chain execution platform.
- Offers tracing and tracking solutions for various industries.
- Focuses on sustainability within supply chains.
- Serves enterprise customers in pharmaceuticals, healthcare, logistics, and agriculture.
- Aims to improve supply chain visibility and control.
- Helps companies meet regulatory compliance requirements.
How Does SPLTF Make Money?
- Generates revenue through subscription fees for its SaaS platform.
- Targets enterprise customers with recurring revenue potential.
- Offers customized solutions tailored to specific industry needs.
What Industry Does SPLTF Operate In?
SpotLite360 operates within the healthcare information services industry, which is experiencing growth driven by the increasing need for supply chain visibility, regulatory compliance, and sustainability. The market for supply chain management software is competitive, with established players and emerging startups vying for market share. SpotLite360's focus on specific industries like pharmaceuticals and healthcare allows it to tailor its solutions and potentially gain a competitive advantage. The industry is also influenced by technological advancements such as blockchain and IoT, which are being integrated into supply chain solutions.
Who Are SPLTF's Key Customers?
- Pharmaceutical companies seeking to track and trace drugs.
- Healthcare providers aiming to improve supply chain efficiency.
- Logistics companies looking to enhance visibility and control.
- Agricultural businesses focused on sustainability and traceability.
SPLTF Financials
SPLTF Latest News
No recent news available for SPLTF.
SPLTF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SPLTF.
Price Targets
Wall Street price target analysis for SPLTF.
SPLTF MoonshotScore
What does this score mean?
The MoonshotScore rates SPLTF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Timothy Harvie
CEO
Timothy Harvie serves as the CEO of SpotLite360 IOT Solutions, Inc. His background includes experience in technology and business development, with a focus on building and scaling SaaS companies. He has a track record of leading teams and driving innovation in the technology sector. Further details regarding his specific educational background and previous roles are not available.
Track Record: Since assuming the role of CEO, Timothy Harvie has focused on expanding SpotLite360's customer base and enhancing its platform's capabilities. Key milestones under his leadership include securing partnerships with logistics providers and expanding the company's presence in the pharmaceutical and agricultural sectors. However, the company's financial performance remains a challenge, with negative profit margins and a need for improved operational efficiency.
SPLTF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that SpotLite360 may not meet the minimum financial or disclosure requirements for higher tiers like OTCQB or OTCQX. Companies in this tier may have limited financial information available and may be subject to greater risks. Investing in companies on the OTC Other tier carries a higher degree of risk compared to companies listed on major exchanges like the NYSE or NASDAQ due to less stringent listing requirements and reduced regulatory oversight. This tier often includes shell companies, penny stocks, and companies with distressed financials.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited liquidity due to OTC listing.
- Lack of transparency due to unknown disclosure status.
- Higher potential for price manipulation.
- Greater risk of fraud or misrepresentation.
- Limited regulatory oversight compared to major exchanges.
- Verify the company's financial reporting standards and the availability of audited financial statements.
- Assess the company's management team and their track record.
- Review the company's business plan and growth strategy.
- Evaluate the company's competitive landscape and market position.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- Operation as a SaaS company indicates a structured business model.
- Focus on supply chain solutions addresses a real market need.
- Presence in the pharmaceutical and healthcare sectors suggests potential for growth.
- Company has been in operation since 2014, indicating some level of stability.
SpotLite360 IOT Solutions, Inc. Healthcare Stock: Key Questions Answered
What does SpotLite360 IOT Solutions, Inc. do?
SpotLite360 IOT Solutions, Inc. provides a SaaS-based platform, Spotlite360, designed to improve supply chain execution, tracing, tracking, and sustainability. The company targets enterprise customers in the pharmaceutical, healthcare, logistics, and agricultural industries. The platform aims to provide end-to-end visibility and control over supply chains, addressing critical needs for product integrity, regulatory compliance, and operational efficiency. Spotlite360's focus on sustainability also aligns with increasing corporate and consumer demand for environmentally responsible practices, offering a comprehensive solution for companies seeking to optimize their supply chain operations.
What do analysts say about SPLTF stock?
As of 2026-03-18, there is no readily available analyst coverage for SpotLite360 IOT Solutions, Inc. (SPLTF) due to its OTC listing and small market capitalization. Investors should conduct their own thorough research and due diligence before making any investment decisions. Key valuation metrics, such as P/E ratio, are currently negative, reflecting the company's losses. Growth considerations include the company's ability to expand its customer base and improve its financial performance. Monitor the company's financial reports and press releases for updates on its progress.
What are the main risks for SPLTF?
The main risks for SpotLite360 IOT Solutions, Inc. include its negative profit margin, which raises concerns about its financial sustainability. The company also faces intense competition from established players in the supply chain management software market. Additionally, its OTC listing may limit investor access and liquidity. Technological advancements could render the platform obsolete if the company fails to innovate and adapt. An economic downturn could reduce demand for supply chain solutions, impacting the company's revenue. Investors should carefully consider these risks before investing in SPLTF.
How does SpotLite360 IOT Solutions, Inc. ensure data security and compliance in the healthcare sector?
Given the sensitive nature of healthcare data, SpotLite360 IOT Solutions, Inc. must implement robust security measures and comply with regulations such as HIPAA (Health Insurance Portability and Accountability Act) in the United States and PIPEDA (Personal Information Protection and Electronic Documents Act) in Canada. These measures include data encryption, access controls, and regular security audits. The company's platform must also be designed to protect patient privacy and prevent data breaches. Failure to comply with these regulations could result in significant fines and reputational damage. Investors should assess the company's commitment to data security and compliance as a key factor in its long-term success.
What is SpotLite360 IOT Solutions, Inc.'s strategy for managing regulatory changes in the pharmaceutical supply chain?
The pharmaceutical supply chain is subject to stringent regulations aimed at ensuring product safety and preventing counterfeiting. SpotLite360 IOT Solutions, Inc. must stay abreast of these regulations and adapt its platform accordingly. This includes complying with the Drug Supply Chain Security Act (DSCSA) in the United States and similar regulations in other countries. The company's strategy should involve continuous monitoring of regulatory changes, collaboration with industry experts, and proactive updates to its platform to meet evolving requirements. Investors should assess the company's ability to navigate the complex regulatory landscape as a critical factor in its long-term viability.
What are the key factors to evaluate for SPLTF?
SpotLite360 IOT Solutions, Inc. (SPLTF) currently holds an AI score of 42/100, indicating low score. Key strength: SaaS-based platform provides recurring revenue potential. Primary risk to monitor: Intense competition from established players could limit market share gains. This is not financial advice.
How frequently does SPLTF data refresh on this page?
SPLTF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven SPLTF's recent stock price performance?
Recent price movement in SpotLite360 IOT Solutions, Inc. (SPLTF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: SaaS-based platform provides recurring revenue potential. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on OTC-listed companies.
- Financial data may not be fully up-to-date.